Clinical Trials Browser

Phase 2 × Interventional × Neurofibromatosis 2 × Clear all

NCT04374305 2026-05-06

INTUITT-NF2

Phase 2 Recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT04283669 2026-03-13

NF110

Phase 2 Completed

12 enrolled 5 charts

Neurofibromatosis 2

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

Neuroma, Acoustic, Neurofibromatosis 2

NCT03095248 2025-04-22

SEL-TH-1601

Phase 2 Terminated

10 enrolled 9 charts

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT01345136 2024-02-13

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Phase 2 Terminated

Neuroma, Acoustic, Neurofibromatosis 2

NCT02831257 2022-06-13

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Phase 2 Completed

18 enrolled 13 charts

Meningioma, Neurofibromatosis 2

NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

13 enrolled 7 charts

Neuroma, Acoustic, Neurofibromatosis 2

NCT02934256 2021-09-09

Icotinib

Phase 2 Completed

Neuroma, Acoustic, Neurofibromatosis 2

NCT01767792 2021-02-12

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

22 enrolled 14 charts

Neurofibromatosis 2

NCT01125046 2021-01-22

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Phase 2 Completed

50 enrolled 13 charts

Brain Neoplasms, Ependymoma, Meningioma, Neurofibromatosis 1, Neuroma, Acoustic, Neurofibromatosis 2

NCT00911248 2019-04-12

PTC299 for Treatment of Neurofibromatosis Type 2

Phase 2 Terminated

Neurofibromatosis 2, Neurofibromatoses

NCT01207687 2018-08-27

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Phase 2 Completed

14 enrolled 28 charts

Neuroma, Acoustic, Neurofibromatosis 2

NCT01419639 2017-07-18

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Phase 2 Completed

10 enrolled 4 charts

Ependymoma, Meningioma, Neurofibromatosis 2

NCT01490476 2017-05-23

AFINF2

Phase 2 Completed

Vestibulocochlear Nerve Diseases, Neuroma, Acoustic, Otorhinolaryngologic Diseases, Peripheral Nervous System Diseases, Neurofibromatosis 2

NCT02104323 2017-02-09

Endostatin

Phase 2 Completed

Neuroma, Acoustic, Neurofibromatosis 2

NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase 2 Completed

21 enrolled 8 charts

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2 Completed

50 enrolled 6 charts

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases